Procos S.P.A.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 12, 2027The maintenance fee for Process for the synthesis of pirfenidone (US 10,472,325) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for Process for the preparation of midostaurin with high purity (US 11,939,342) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
- 1 fee due Oct 21, 2027The maintenance fee for Process for the synthesis of efinaconazol (US 10,626,102) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,877,935 | One-Pot Process for the Synthesis of Dalfampridine In force · High confidence | In force | High confidence | |
| US 9,518,047 | Process for the industrial synthesis of lurasidone In force · From the USPTO record | In force | From the USPTO record | |
| US 10,472,325 | Process for the synthesis of pirfenidone In force · From the USPTO record | In force | From the USPTO record | |
| US 10,626,102 | Process for the synthesis of efinaconazol In force · From the USPTO record | In force | From the USPTO record | |
| US 11,286,254 | Process for the synthesis of 2-benzhydryl-3 quinuclidinone In force · From the USPTO record | In force | From the USPTO record | |
| US 11,028,057 | Process for the synthesis of 6-chloromethyluracil In force · From the USPTO record | In force | From the USPTO record | |
| US 11,344,550 | Process for the preparation of the crystalline form III of tipiracil hydrochloride In force · From the USPTO record | In force | From the USPTO record | |
| US 11,459,303 | Process for the synthesis of lofexidine In force · From the USPTO record | In force | From the USPTO record | |
| US 11,939,342 | Process for the preparation of midostaurin with high purity In force · From the USPTO record | In force | From the USPTO record | |
| US 12,723,020 | Novel Process for Preparing Solriamfetol Hydrochloride In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 4 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 no status recorded